Diabetic Ketoacidosis Induced by Aripiprazole in a 12-Year-Old Boy
- Radhika Dhamija, MD12 and
- Rajanshu Verma, MD1
- 1Department of Internal Medicine, Michigan State University/Kalamazoo Center for Medical Studies, Kalamazoo, Michigan
- 2Department of Pediatrics, Michigan State University/Kalamazoo Center for Medical Studies, Kalamazoo, Michigan
- Corresponding author: Radhika Dhamija, MD, Departments of Internal Medicine and Pediatrics, Michigan State University/Kalamazoo Center for Medical Studies, 1000 Oakland Dr., Kalamazoo, Michigan 49008. E-mail: dhamijaradhika{at}yahoo.co.in or rdhami{at}msu.kcms.edu
Aripiprazole is a relatively new atypical antipsychotic drug used to treat aggression, bipolar disorder, conduct and mood disorder, and Tourette's syndrome in children and schizophrenia-related mood disturbances in adults. It is believed to have fewer side effects such as weight gain, pancreatitis, and hyperglycemia (1,2). We report a 12-year-old boy who presented with diabetic ketoacidosis (DKA) due to Aripiprazole use.
A 12-year-old Caucasian boy with a history of intractable epilepsy, mental retardation, …
